Review of Neurosurgical Fluorescence Imaging Methodologies

Overview

Journal IEEE J Sel Top Quantum Electron

Publisher IEEE

Date 2010 Jul 31

PMID 20671936

Citations 61

Authors

Brian W Pogue

Summer Gibbs-Strauss

Pablo A Valdes

Kimberley Samkoe

David W Roberts

Keith D Paulsen

Affiliations

Soon will be listed here.

Abstract

Fluorescence imaging in neurosurgery has a long historical development, with several different biomarkers and biochemical agents being used, and several technological approaches. This review focuses on the different contrast agents, summarizing endogenous fluorescence, exogenously stimulated fluorescence and exogenous contrast agents, and then on tools used for imaging. It ends with a summary of key clinical trials that lead to consensus studies. The practical utility of protoporphyrin IX (PpIX) as stimulated by administration of δ-aminolevulinic acid (ALA) has had substantial pilot clinical studies and basic science research completed. Recently multi-center clinical trials using PpIx fluorescence to guide resection have shown efficacy for improved short term survival. Exogenous agents are being developed and tested pre-clinically, and hopefully hold the potential for long term survival benefit if they provide additional capabilities for resection of micro-invasive disease or certain tumor sub-types that do not produce PpIX or help delineate low grade tumors. The range of technologies used for measurement and imaging ranges widely, with most clinical trials being carried out with either point probes or modified surgical microscopes. At this point in time, optimized probe approaches are showing efficacy in clinical trials, and fully commercialized imaging systems are emerging, which will clearly help lead to adoption into neurosurgical practice.

Citing Articles

Fluorescent probes for sensing and visualizing methylglyoxal: progress, challenges, and perspectives.

Wen J, Zhang Q, Zhou L RSC Adv. 2024; 14(52):38757-38777.

PMID: 39659598 PMC: 11629108. DOI: 10.1039/d4ra07512a.

Hyperspectral imaging in neurosurgery: a review of systems, computational methods, and clinical applications.

Kotwal A, Saragadam V, Bernstock J, Sandoval A, Veeraraghavan A, Valdes P J Biomed Opt. 2024; 30(2):023512.

PMID: 39544341 PMC: 11559659. DOI: 10.1117/1.JBO.30.2.023512.

Safety, efficacy, and side effects of sodium fluorescein-aided resection of glioblastoma: a quasi-experimental study.

Ahmed N, Hossain M, Ahmed R, Abbasi M, Azab M, Alam M Ann Med Surg (Lond). 2024; 86(11):6521-6530.

PMID: 39525789 PMC: 11543223. DOI: 10.1097/MS9.0000000000002633.

Photodynamic Therapy: Past, Current, and Future.

Aebisher D, Czech S, Dynarowicz K, Misiolek M, Komosinska-Vassev K, Kawczyk-Krupka A Int J Mol Sci. 2024; 25(20).

PMID: 39457108 PMC: 11508366. DOI: 10.3390/ijms252011325.

Pressure-enhanced sensing of tissue oxygenation via endogenous porphyrin: Implications for dynamic visualization of cancer in surgery.

Petusseau A, Ochoa M, Reed M, Doyley M, Hasan T, Bruza P Proc Natl Acad Sci U S A. 2024; 121(34):e2405628121.

PMID: 39141355 PMC: 11348300. DOI: 10.1073/pnas.2405628121.

References

Gibbs S, Chen B, OHara J, Hoopes P, Hasan T, Pogue B . Protoporphyrin IX level correlates with number of mitochondria, but increase in production correlates with tumor cell size. Photochem Photobiol. 2006; 82(5):1334-41. DOI: 10.1562/2006-03-11-RA-843. View

Chang S, MacRobert A, Porter J, Bown S . The efficacy of an iron chelator (CP94) in increasing cellular protoporphyrin IX following intravesical 5-aminolaevulinic acid administration: an in vivo study. J Photochem Photobiol B. 1997; 38(2-3):114-22. DOI: 10.1016/s1011-1344(96)07441-6. View

Wyld L, Smith O, Lawry J, Reed M, Brown N . Cell cycle phase influences tumour cell sensitivity to aminolaevulinic acid-induced photodynamic therapy in vitro. Br J Cancer. 1998; 78(1):50-5. PMC: 2062939. DOI: 10.1038/bjc.1998.441. View

Gupta A, Gupta M . Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials. 2005; 26(18):3995-4021. DOI: 10.1016/j.biomaterials.2004.10.012. View

Trehin R, Figueiredo J, Pittet M, Weissleder R, Josephson L, Mahmood U . Fluorescent nanoparticle uptake for brain tumor visualization. Neoplasia. 2006; 8(4):302-11. PMC: 1600680. DOI: 10.1593/neo.05751. View

Gibbs-Strauss S, OHara J, Srinivasan S, Hoopes P, Hasan T, Pogue B . Diagnostic detection of diffuse glioma tumors in vive with molecular fluorescent probe-based transmission spectroscopy. Med Phys. 2009; 36(3):974-83. PMC: 2736749. DOI: 10.1118/1.3075770. View

Hebeda K, Saarnak A, Olivo M, Sterenborg H, Wolbers J . 5-Aminolevulinic acid induced endogenous porphyrin fluorescence in 9L and C6 brain tumours and in the normal rat brain. Acta Neurochir (Wien). 1998; 140(5):503-12; discussion 512-3. DOI: 10.1007/s007010050132. View

Stummer W, Pichlmeier U, Meinel T, Wiestler O, Zanella F, Reulen H . Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol. 2006; 7(5):392-401. DOI: 10.1016/S1470-2045(06)70665-9. View

Sterenborg H, Saarnak A, Frank R, Motamedi M . Evaluation of spectral correction techniques for fluorescence measurements on pigmented lesions in vivo. J Photochem Photobiol B. 1996; 35(3):159-65. DOI: 10.1016/s1011-1344(96)07320-4. View

10.

Sarin H, Kanevsky A, Wu H, Brimacombe K, Fung S, Sousa A . Effective transvascular delivery of nanoparticles across the blood-brain tumor barrier into malignant glioma cells. J Transl Med. 2008; 6:80. PMC: 2639552. DOI: 10.1186/1479-5876-6-80. View

11.

Chen X, Conti P, Moats R . In vivo near-infrared fluorescence imaging of integrin alphavbeta3 in brain tumor xenografts. Cancer Res. 2004; 64(21):8009-14. DOI: 10.1158/0008-5472.CAN-04-1956. View

12.

Haglund M, Berger M, Hochman D . Enhanced optical imaging of human gliomas and tumor margins. Neurosurgery. 1996; 38(2):308-17. DOI: 10.1097/00006123-199602000-00015. View

13.

Morofuji Y, Matsuo T, Hayashi Y, Suyama K, Nagata I . Usefulness of intraoperative photodynamic diagnosis using 5-aminolevulinic acid for meningiomas with cranial invasion: technical case report. Neurosurgery. 2008; 62(3 Suppl 1):102-3. DOI: 10.1227/01.neu.0000317378.22820.46. View

14.

Iyer A, Khaled G, Fang J, Maeda H . Exploiting the enhanced permeability and retention effect for tumor targeting. Drug Discov Today. 2006; 11(17-18):812-8. DOI: 10.1016/j.drudis.2006.07.005. View

15.

Pogue B, Burke G . Fiber-optic bundle design for quantitative fluorescence measurement from tissue. Appl Opt. 2008; 37(31):7429-36. DOI: 10.1364/ao.37.007429. View

16.

Gebhart S, Thompson R, Mahadevan-Jansen A . Liquid-crystal tunable filter spectral imaging for brain tumor demarcation. Appl Opt. 2007; 46(10):1896-910. DOI: 10.1364/ao.46.001896. View

17.

Stummer W, Stocker S, Wagner S, Stepp H, Fritsch C, Goetz C . Intraoperative detection of malignant gliomas by 5-aminolevulinic acid-induced porphyrin fluorescence. Neurosurgery. 1998; 42(3):518-25; discussion 525-6. DOI: 10.1097/00006123-199803000-00017. View

18.

Sinaasappel M, Sterenborg H . Quantification of the hematoporphyrin derivative by fluorescence measurementusing dual-wavelength excitation anddual-wavelength detection. Appl Opt. 2010; 32(4):541-8. DOI: 10.1364/AO.32.000541. View

19.

Kuroiwa T, Kajimoto Y, Ohta T . Comparison between operative findings on malignant glioma by a fluorescein surgical microscopy and histological findings. Neurol Res. 1999; 21(1):130-4. DOI: 10.1080/01616412.1999.11740909. View

20.

Hansen D, Spence A, Carski T, Berger M . Indocyanine green (ICG) staining and demarcation of tumor margins in a rat glioma model. Surg Neurol. 1993; 40(6):451-6. DOI: 10.1016/0090-3019(93)90046-4. View